CODX vs OKTA · rev $3.9M vs P/E 84, rev $2.61B
Co-Diagnostics, Inc. Common Stock (CODX) versus Okta Inc (OKTA) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported OKTA revenue for 2025-01-31 was $2.61B. Net income was $28.0M. Revenue was up 15.3% from 2024-01-31 to 2025-01-31. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
CODX currently screens at market cap $31.4M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
Not investment advice. Open the CODX and OKTA stock pages for the full models.
Not investment advice.